PARTNERSHIP BETWEEN CHEM-X-INFINITY AND XANCHEM
Xanchem is a chemical company specializing in radical chemistry, gold chemistry and multi-component reactions. Xanchem designs, develops and manufactures original heterocyclic, aromatic, and heteroaromatic derivatives, which are particularly suitable as synthons and scaffolds for the early stages of drug discovery programs. Its expertise includes original tetrahydropyridoindoles, pyrrolopyridines, naphtyridines and benzothiepinones.
CHEM-X-INFINITY is pleased to announce it has signed a partnership with XANCHEM for the design of new original libraries. The libraries will explore the diversity space around XANCHEM’s original scaffolds. Based on our property predictions, the selected molecules could have applications in the kinases, ion channels and proteases fields. The molecules are designed to fully respect the Lipinski rules to offer ideal compounds for first intention screenings.
The partnership is a long term commitment with the objective to develop several thematic libraries. The first library having applications in the oncology field will be released in 2014.